(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ: PACB) dropped 8.04% to $4.18 at 13:31 EST on Friday, after five sequential sessions in a row of losses. NASDAQ is falling 3.45% to $11,348.32, after two successive sessions in a row of losses. This seems, as yet, a very down trend exchanging session today.
Pacific Biosciences of California’s last close was $4.54, 87.51% under its 52-week high of $36.36.
Volume
Today’s last reported volume for Pacific Biosciences of California is 4384157 which is 37.04% below its average volume of 6964434.
Pacific Biosciences of California’s Sales
Pacific Biosciences of California’s sales growth is 17% for the current quarter and 30.3% for the next. The company’s growth estimates for the current quarter and the next is a negative 57.1% and a negative 500%, respectively.
Pacific Biosciences of California’s Revenue
Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.
Volatility
Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.93%, a negative 0.72%, and a positive 5.94%, respectively.
Pacific Biosciences of California’s highest amplitude of average volatility was 2.93% (last week), 6.69% (last month), and 5.94% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Pacific Biosciences of California’s stock is considered to be overbought (>=80).
Pacific Biosciences of California’s Stock Yearly Top and Bottom Value
Pacific Biosciences of California’s stock is valued at $4.18 at 13:31 EST, under its 52-week low of $4.51.
Pacific Biosciences of California’s Moving Average
Pacific Biosciences of California’s value is way under its 50-day moving average of $7.39 and way under its 200-day moving average of $17.48.
More news about Pacific Biosciences of California (PACB).
